<html lang="en"><meta name="viewport" content="width=device-width, initial-scale=1" /><head><!-- Global site tag (gtag.js) - Google Analytics --><script async src="https://www.googletagmanager.com/gtag/js?id=G-2VYEP6CXDE"></script><script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag("js", new Date());  gtag("config", "G-2VYEP6CXDE");</script><link rel="stylesheet" href="../init.css"><title>Black Americans have overtaken white victims in opioid death rates</title></head><body><div class="ds-layout-grid ds-layout-grid--edged layout-article-header"><script type="application/ld+json">
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://www.economist.com/united-states/","name":"United States"}},{"@type":"ListItem","position":2,"item":{"@id":"https://www.economist.com/printedition/2022-04-09","name":"Apr 9th 2022 edition"}}]}
</script><div class="article__section"><strong itemprop="articleSection"><span class="article__section-headline"><a href="https://www.economist.com/united-states/">United States</a></span></strong><a class="article__section-edition" data-test-id="Article Datetime" href="/printedition/2022-04-09"><span>Apr 9th 2022<!-- --> edition</span></a></div><header class="article__header"><h1><span class="article__subheadline" data-test-id="Article Subheadline">The opioid epidemic</span><br/><span class="article__headline" data-test-id="Article Headline" itemprop="headline">Black Americans have overtaken white victims in opioid death rates</span></h1><h2 class="article__description" data-test-id="Article Description" itemprop="description">The reasons for a lethal shift</h2></header><hr class="ds-rule layout-article-header__rule"/></div><div class="ds-layout-grid ds-layout-grid--edged layout-article-body"><figure class="interactive-figure"><iframe data-size="full-width" height="NaN" src="https://www.economist.com/assets/infographic/2022/interactive-opioids-black-america/photo.html"></iframe></figure><p class="article__body-text article__body-text--dropcap" data-caps="initial"><span data-caps="initial">T</span><small>HE TYPICAL</small> face of America’s opioid epidemic has long been that of a white man from a post-industrial town in the Appalachian mountains. White victims have accounted for 78% of the more than 500,000 opioid-overdose deaths since the late 1990s. In 2017 counties in Appalachia experienced rates 72% higher than the average for the rest of the country.</p><div class="article-audio-player"><figure class="article-audio-player__figure"><div><figcaption>Listen to this story.</figcaption> <span class="article-audio-player__cta">Enjoy more audio and podcasts on<!-- --> <a href="https://apps.apple.com/app/apple-store/id1239397626?pt=344884&amp;ct=article%20audio%20player&amp;mt=8" id="audio-ios-cta" rel="noreferrer" target="_blank">iOS</a> <!-- -->or<!-- --> <a href="https://play.google.com/store/apps/details?id=com.economist.lamarr&amp;referrer=utm_source%3Darticle%2520audio%2520player" id="audio-android-cta" rel="noreferrer" target="_blank">Android</a>.</span></div><audio class="react-audio-player" controls="" controlslist="nodownload" id="audio-player" preload="none" src="../audio/black-americans-have-overtaken-white-victims-in-opioid-death-rates.mp3" title="Black Americans have overtaken white victims in opioid death rates"><p>Your browser does not support the &lt;audio&gt; element.</p></audio><div class="article-audio-player__center-tooltip" data-optimizely="audio-tooltip" style="display:none"><style data-emotion="css sl0bi6">.css-sl0bi6{position:relative;display:inline-block;text-align:left;}</style><div class="css-sl0bi6 ey1yhxa8"><style data-emotion="css 11m9t22">.css-11m9t22{z-index:98;height:40px;width:40px;position:absolute;border-radius:50%;box-shadow:0 0 0 0 rgba(0, 0, 0, 1);-webkit-transform:scale(1);-moz-transform:scale(1);-ms-transform:scale(1);transform:scale(1);-webkit-animation:pulse-color 2s infinite;animation:pulse-color 2s infinite;}.css-11m9t22 circle{stroke:var(--ds-color-new-york-55);opacity:0.6;}@media (max-width: 22.4375rem){.css-11m9t22{top:calc(100% - 20px);left:calc(50% - 20px);}}@media (min-width: 22.5rem){.css-11m9t22{top:calc(100% - 20px);left:calc(50% - 20px);}}@-webkit-keyframes pulse-color{0%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0.7);}70%{-webkit-transform:scale(1);-moz-transform:scale(1);-ms-transform:scale(1);transform:scale(1);box-shadow:0 0 0 10px rgba(249, 195, 31, 0);}100%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0);}}@keyframes pulse-color{0%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0.7);}70%{-webkit-transform:scale(1);-moz-transform:scale(1);-ms-transform:scale(1);transform:scale(1);box-shadow:0 0 0 10px rgba(249, 195, 31, 0);}100%{-webkit-transform:scale(0.95);-moz-transform:scale(0.95);-ms-transform:scale(0.95);transform:scale(0.95);box-shadow:0 0 0 0 rgba(249, 195, 31, 0);}}</style><div class="css-11m9t22 ey1yhxa6"><svg aria-hidden="true" viewbox="0 0 100 100" xmlns="http://www.w3.org/2000/svg"><circle cx="50" cy="50" fill="transparent" r="18" stroke-width="12"></circle><circle cx="50" cy="50" fill="transparent" r="38" stroke-width="12"></circle></svg></div><style data-emotion="css 1uzxrld">.css-1uzxrld{z-index:99;position:absolute;}@media (max-width: 22.4375rem){.css-1uzxrld{top:100%;left:calc(50% - 130px);}}@media (min-width: 22.5rem){.css-1uzxrld{top:100%;left:calc(50% - 130px);}}</style><div class="css-1uzxrld ey1yhxa7"><style data-emotion="css 12d2uoj">.css-12d2uoj{box-sizing:border-box;background-color:white;font-family:var(--ds-type-system-sans);display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;gap:0.75rem;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;padding:1.5rem;-webkit-filter:drop-shadow(rgba(0, 0, 0, 0.15) 0 4px 16px);filter:drop-shadow(rgba(0, 0, 0, 0.15) 0 4px 16px);border-color:var(--ds-color-london-85);border:1px solid var(--ds-color-los-angeles-85);border-radius:0.5rem;width:260px;}</style><div class="css-12d2uoj ey1yhxa5"><style data-emotion="css 4c6dm7">.css-4c6dm7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-box-pack:justify;-webkit-justify-content:space-between;justify-content:space-between;}</style><div class="css-4c6dm7 ey1yhxa4"><style data-emotion="css t9wkhq">.css-t9wkhq{color:var(--ds-color-london-5);display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:end;-webkit-box-align:end;-ms-flex-align:end;align-items:end;font-size:var(--ds-type-scale-2);font-weight:500;line-height:var(--ds-type-leading-lower);}</style><div class="css-t9wkhq ey1yhxa3">Listen to this story</div><style data-emotion="css 1d5zrco">.css-1d5zrco{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;color:var(--ds-color-london-20);}.css-1d5zrco>button{height:24px;width:24px;}.css-1d5zrco>button .path-background{fill:var(--ds-color-london-35);}</style><div class="css-1d5zrco ey1yhxa2"><button aria-label="Close" class="ds-control-close _close" type="button"><svg viewbox="5 5 14 14" width="100%" xmlns="http://www.w3.org/2000/svg"><path class="path-background" d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"></path></svg></button></div></div><style data-emotion="css 1mts01m">.css-1mts01m{color:var(--ds-color-london-35);font-size:var(--ds-type-scale--1);line-height:var(--ds-type-leading-lower);margin-bottom:1rem;font-weight:400;}</style><div class="css-1mts01m ey1yhxa1"><span>Save time by listening to our audio articles as you multitask</span></div><style data-emotion="css 1cosuf1">.css-1cosuf1{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;-webkit-box-pack:justify;-webkit-justify-content:space-between;justify-content:space-between;}.css-1cosuf1>.ds-navigation-link>span{font-size:var(--ds-type-scale-0);line-height:var(--ds-type-leading-upper);color:var(--ds-color-london-35);border-bottom:1px solid var(--ds-color-london-35);}</style><div class="css-1cosuf1 ey1yhxa0"><button class="ds-slim-button" type="button">OK</button></div></div></div></div></div></figure></div><p class="article__body-text">African-Americans were, for once, far less affected. But that has changed. In 2020 their rate of opioid-related deaths surpassed white people’s—the culmination of a grim trend some five years in the making.</p><p class="article__body-text">The first wave of the epidemic was caused by drug companies and doctors pushing prescription opioids. Researchers theorise that twisted beliefs (that African-Americans are more likely to divert pills for street use, and are less sensitive to pain so do not need them anyway) helped to insulate them from the scourge relative to white Americans. Then, from 2010, came a second wave: as regulators clamped down on prescription pills, many addicts turned to illicit opioids, notably heroin. White addicts continued to fatally overdose at over twice the rate of black users.</p><p class="article__body-text">Fentanyl, a synthetic opioid up to 50 times more potent than heroin, brought a third wave. Though it is also a prescription painkiller, its illicit form—mainly made in Mexico with materials from China—has contaminated drugs. Its low cost and powerful high make it attractive: dealers can dilute the more expensive drugs they sell, such as cocaine, heroin or methamphetamine, while strengthening their effect.</p><figure class="g-fallback" data-infographic-class="g-fallback"></figure><figure class="g-fallback" data-infographic-class="g-fallback"></figure><figure class="interactive-figure"><iframe data-size="full-width" height="NaN" src="https://www.economist.com/assets/infographic/2022/interactive-opioids-black-america/frame.html"></iframe></figure><p class="article__body-text">Especially so for older black men. In 2020 black men aged 55 to 64 died at over 2.5 times the rate of older white men. Andrew Kolodny, medical director of opioid-policy research at Brandeis University, describes some of these victims as survivors of the heroin epidemic that devastated inner cities in the 1960s and 70s. Unaware that a more powerful synthetic opioid had contaminated their supply, “older black men who managed to beat the odds and survive for decades started dying,” explains Dr Kolodny.</p><p class="article__body-text">George (not his real name), a 55-year-old West Baltimore native, has struggled with addiction since he was a teenager. In the four decades since he was first handed powdered heroin wrapped in a dollar bill the landscape has changed: “You used to be able to get a quality bag of heroin. Now you have this synthetic drug out here on the streets everywhere.” He now uses fentanyl regularly and estimates he has overdosed on it four times in the past couple of years. “When you’re messing with this stuff, everything’s a blur,” he says. “I don’t know how I keep outliving people, but I really don’t want to leave this Earth an addict.”</p><div class="advert incontent hidden advert--inline"><div><div class="adcontainer" id="econ-1"></div></div></div><p class="article__body-text">The poison has crept into stimulants, too. Overdose deaths attributed to psycho stimulants used with opioids have risen. Some are referring to this as a fourth wave of the epidemic. For those unaccustomed to opioids or “speedballing” (mixing stimulants with opioids), fentanyl is “a shock to the system, shutting down your breathing and heart rate”, says Keith Humphreys, a professor of psychiatry at Stanford University. Some 35% of African-Americans who died of overdoses in 2020 had both cocaine and fentanyl in their system, compared with 16% of white victims.</p><p class="article__body-text">Poor people are more than twice as likely to die of opioid overdose. One-fifth of African-Americans live in poverty. Fully 40% of all homeless people and 38% of prisoners are black (compared with just 13% of the overall population). These are all potent risk factors. And though an estimated 65% of America’s prisoners suffer from a substance-use disorder of some sort, there is little access to good treatment either during incarceration or upon release.</p><p class="article__body-text">Treatment for opioid use disorder (<small>OUD</small>) is woefully inadequate across the country, but African-Americans often face extra barriers. Studies have found that medications for treating <small>OUD,</small> as well as naloxone (a life-saving medication that reverses opioid overdoses), are doled out unevenly. A study of data from Medicaid, the government insurance programme for the poor, across several states with some of the highest opioid-overdose rates found that between 2014 and 2018 black people with <small>OUD</small> were 28% less likely to use <small>OUD</small> medications.</p><p class="article__body-text">Studies in various cities, including San Francisco and Los Angeles, suggest that African-Americans have less access to naloxone, too. In Detroit between 2019 and 2020, white addicts received 28% of naloxone administrations, though they accounted for 17% of the city’s opioid overdoses; although 80% of overdoses were among black people, they received only 67% of naloxone administrations. This does not necessarily mean black addicts are being denied naloxone. Those who use opioids alone, are homeless or live in communities with little trust in first responders might be less likely to call for help.</p><p class="article__body-text">Such disparities strengthen the case for local interventions that deal with the unique hurdles certain communities face. Other solutions are more sweeping, like expanding access to Medicaid and reducing red tape around <small>OUD</small> medications. But underlying all these is a straightforward calculus that applies to all Americans, black or white: “It has to be easier to get treated than it is to continue using,” says Dr Kolodny. “You have to flip it.” <span data-ornament="ufinish">■</span></p><figure data-infographic-js="1"></figure><p class="article__footnote" data-test-id="Footnote">This article appeared in the United States section of the print edition under the headline "A lethal shift"</p><div class="layout-article-links layout-article-promo"><a class="ds-actioned-link ds-actioned-link--reuse-this-content" href="https://s100.copyright.com/AppDispatchServlet?publisherName=economist&amp;publication=economist&amp;title=Black%20Americans%20have%20overtaken%20white%20victims%20in%20opioid%20death%20rates&amp;publicationDate=2022-04-09&amp;contentID=%2Fcontent%2Fclmaum73sr9gdq6k57nvfvgrcm071q5b&amp;type=A&amp;orderBeanReset=TRUE" target="_blank"><span>Reuse this content</span></a><a class="ds-actioned-link ds-actioned-link--the-trust-project" href="https://www.economist.com/frequently-asked-questions"><span>The Trust Project</span></a></div></div></body></html>